Sit Investment Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$53.7M |
| 2 |
Walmart Inc
WMT
|
+$47.9M |
| 3 |
General Dynamics
GD
|
+$44.6M |
| 4 |
Whirlpool
WHR
|
+$43.4M |
| 5 |
Gilead Sciences
GILD
|
+$40.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$46.7M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$44.2M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$42.1M |
| 4 |
Chevron
CVX
|
+$38.8M |
| 5 |
Diageo
DEO
|
+$27.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.38% |
| 2 | Industrials | 11.91% |
| 3 | Technology | 11.79% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Financials | 9.54% |
Similar funds
Sit Investment Associates's Q1 2015 Portfolio in Review
As of Q1 2015, Sit Investment Associates held 461 positions worth $5.77B, down 4.2% from $6.02B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Sit Investment Associates withdrew a net $320M in Q1 2015, closing 35 positions and reducing 232 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $44.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.
Against the trend, Sit Investment Associates opened a new position in AbbVie worth $52M.
- Sit Investment Associates's largest Q1 2015 buy was AbbVie: 888,791 shares worth $52M.
- Sit Investment Associates added most to Gilead Sciences in Q1 2015, an estimated $40.2M increase.
- Sit Investment Associates's biggest Q1 2015 reduction was Qualcomm, cutting an estimated $46.7M.
- Sit Investment Associates fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $44.2M.
- Sit Investment Associates's ten largest holdings make up 18% of its $5.77B portfolio in Q1 2015.
- Sit Investment Associates opened 36 new positions and closed 35 in Q1 2015.
- Sit Investment Associates's portfolio value fell 4.2% quarter-over-quarter to $5.77B.
Based on Sit Investment Associates's 13F filing for Q1 2015, filed 30 Apr 2015.